Christine Pfaff, Director of Clinical Initiatives at Community Oncology Alliance, shared on LinkedIn:
“The Center for Cancer and Blood Disorders in Texas offers CAR T-cell therapy to patients in the community oncology setting.
Why?
‘We have a lot of patients who do not have access because they live far from academic medical centers or large hospitals.’
Using AI and remote therapeutic monitoring as a tool also helps CCBD support their patients.”